Walleye Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Walleye Trading’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,978	Closed	-$640K	–	4889
2020 Q3	$640K	Buy	2,978 +2,279	+326%	+$491K	﹤0.01%	2027
2020 Q2	$150K	Hold	699	–	–	﹤0.01%	3273
2020 Q1	$147K	Sell	699 -4,550	-87%	-$954K	﹤0.01%	2864
2019 Q4	$1.1M	Buy	5,249 +28	+0.5%	+$5.84K	0.01%	1717
2019 Q3	$1.08M	Sell	5,221 -475	-8%	-$97.9K	0.01%	1541
2019 Q2	$1.16M	Sell	5,696 -3,663	-39%	-$745K	0.01%	1463
2019 Q1	$1.89M	Buy	+9,359	New	+$1.88M	0.01%	1127

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Walleye Trading's RVPH Position: Q4 2020 in Review

Walleye Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 2,978 shares — an estimated $640K sold.

Walleye Trading first reported a position in RVPH in Q1 2019 and held it in 7 quarters. The position peaked at $1.89M in Q1 2019. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

Walleye Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 2,978 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $640K.
Walleye Trading first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 7 quarters.
Walleye Trading's REVIVA PHARMA HLDGS INC position peaked at $1.89M in Q1 2019.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.